96
Views
3
CrossRef citations to date
0
Altmetric
Perspectives

How can we enable drug discovery informatics for personalized healthcare?

Pages 219-224 | Published online: 16 Jan 2011

Bibliography

  • Kola I. The state of innovation in drug development. Clin Pharmacol Ther 2008;83(2):227-30
  • Giacomini KM, Krauss RM, Roden DM, When good drugs go bad. Nature 2007;446(7139):975-7
  • Classen DC, Pestotnik SL, Evans RS, Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. J Am Med Assoc 1997;277(4):301-6
  • Scheiber J, Jenkins JL, Sukuru SCK, Mapping adverse drug reactions in chemical space. J Med Chem 2009;52(9):3103-7
  • Squassina A, Manchia M, Manolopoulos VG, Realities and expectations of pharmacogenomics and personalized medicine: impact of translating genetic knowledge into clinical practice. Pharmacogenomics 2010;11(8):1149-67
  • Harris T. Gene and drug matrix for personalized cancer therapy. Nat Rev Drug Discov 2010;9(660). Doi: 10.1038/nrd3181-c1
  • Papadopoulos N, Kinzler KW, Vogelstein B. The role of companion diagnostics in the development and use of mutation-targeted cancer therapies. Nat Biotechnol 2006;24:985-95
  • Harris TJR, McCormick F. The molecular pathology of cancer. Nat Rev Clin Oncol 2010;7:251-65
  • Goble C, Stevens R. State of the nation in data integration for bioinformatics. J Biomed Inform 2008;41:687-93
  • Goble C. Intractable problem in bioinformatics. Available from: www.cs.man.ac.uk/∼carole/Talks/BOSCsevensinsGOBLE.ppt, retrieved 5 September 2010
  • Available from: http://databases.biomedcentral.com/, retrieved 5 September 2010
  • Bader GD, Cary MP, Sander C. Pathguide: a pathway resource list. Nucleic Acids Res 2006;34(Database issue):D504-6
  • Nelson B. Empty. Arch Nat 2009;461:160-3
  • Butte AJ. Translational bioinformatics: coming of age. J Am Med Inform Assoc 2008;15(6):709-14
  • Kant CS, Ibberson MR, Scheer A. Building a disease knowledge environment to lay the foundations for in silico drug discovery and translational medicine. Expert Opin Drug Discov 2010;5(2):117-22
  • Available from: http://bioinformatics.roslin.ac.uk/lawslaws/: “All scientists agree that sharing data is good and are more than happy to share everyone else's”, retrieved 4 September 2010
  • Available from: http://www.c-path.org/CAMDcodr.cfm The Coalition Against Major Diseases (CAMD) has made the C-Path Online Data Repository (CODR) available to qualified researchers. The database contains the de-identified control arm data of over 4000 patients from eleven Alzheimer's disease clinical trials
  • Chen R, Sigdel TK, Li L, Differentially expressed RNA from public microarray data identifies serum protein biomarkers for cross-organ transplant rejection and other conditions. PLoS Comput Biol 2010;6(9):1-12
  • Chaussabel D, Ueno H, Banchereau J, Quinn C. Data management: it starts at the bench. Nat Immunol 2009;10(12):1225-7
  • Mullin R. Next-generation DNA sequencing raises the bar in laboratory data management. Chem Eng News 2009;87(21). Available from: http://pubs.acs.org/cen/coverstory/87/8721cover2.html
  • Hawkins RD, Hon GC, Ren B. Next-generation genomics: an integrative approach. Nat Rev Genet 2010;11:476-86
  • Agrafiotis DK, Alex S, Dai H, Advanced biological and chemical discovery (ABCD): centralizing discovery knowledge in an inherently decentralized world. J Chem Inf Model 2007;47(6):1999-2014
  • Cheung KH, Prud'hommeaux E, Wang Y, Stephens S. Semantic Web for health care and life sciences: a review of the state of the art. Brief Bioinform 2009;10(2):111-13
  • Searls DB. Data integration: challenges for drug discovery. Nat Rev Drug Discov 2005;4:45-58
  • Paolini GV, Shapland RH, van Hoorn WP, Global mapping of pharmacological space. Nat Biotechnol 2006;24(7):805-15
  • Slater T, Bouton C, Huang ES. Beyond data integration. Drug Discov Today 2008;13(13-14):584-9
  • Szalma S, Koka V, Khasanova T, Perakslis ED. Effective knowledge management in translational medicine. J Transl Med 2010;8(68). Doi: 10.1186/1479-5876-8-68
  • Perakslis ED, Van Dam J, Szalma S. How informatics can potentiate precompetitive open-source collaboration to jump-start drug discovery and development. Clin Pharmacol Ther 2010;87(5):614-16
  • Alquier L, Schultz T, Stephens S. Exploration of a data landscape using a collaborative linked data framework. Paper presented at: Proceedings of the Workshop on the Future of the Web for Collaborative Science (WWW2010), 2010
  • Verbeeck R, Schultz T, Alquier L, Stephens S. Relational to RDF mapping using D2R for translational research in neuroscience, ISMB 2010
  • Cochrane GR, Galperin MY. The 2010 Nucleic Acids Research Database Issue and online Database Collection: a community of data resources. Nucl Acids Res 2010;38(Suppl 1):D1-4
  • Sayers EW, Barrett T, Benson DA, Database resources of the National Center for Biotechnology Information. Nucl Acids Res 2010;38(Suppl 1):D5-D16
  • Marcial LH, Hemminger BM. Scientific data repositories on the Web: an initial survey. J Am Soc Inform Sci Technol 2010; DOI: 10.1002/asi.21339 Early View
  • Barabasi AL, Albert R. Emergence of scaling in random networks. Science 1999;286(5439):509-12
  • Granovetter MS. The strength of weak ties. AJS 1973;78(6):1360-80
  • Woodcock J. Precompetitive research: a new prescription for drug development? Clin Pharmacol Ther 2010;87(5):521-3

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.